136 related articles for article (PubMed ID: 29581984)
1. Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Xu X; Lu J; Wang F; Liu X; Peng X; Yu B; Zhao F; Li X
Biomed Res Int; 2018; 2018():7329195. PubMed ID: 29581984
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis.
Wang J; Xu Y; Wang J; Ying H
Clin Chim Acta; 2020 Apr; 503():54-60. PubMed ID: 31926154
[TBL] [Abstract][Full Text] [Related]
3. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
4. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis.
Lu J; Xu X; Liu X; Peng Y; Zhang B; Wang L; Luo H; Peng X; Li G; Tian W; He M; Li X
Br J Cancer; 2014 Jan; 110(2):392-8. PubMed ID: 24327016
[TBL] [Abstract][Full Text] [Related]
6. Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs.
Li K; Zhu X; Li L; Ning R; Liang Z; Zeng F; Su F; Huang S; Yang X; Qu S
Sci Rep; 2020 Mar; 10(1):5161. PubMed ID: 32198434
[TBL] [Abstract][Full Text] [Related]
7. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
8. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
9. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
10. Direct quantification of circulating miRNAs in different stages of nasopharyngeal cancerous serum samples in single molecule level with total internal reflection fluorescence microscopy.
Ho SL; Chan HM; Ha AW; Wong RN; Li HW
Anal Chem; 2014 Oct; 86(19):9880-6. PubMed ID: 25207668
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
[TBL] [Abstract][Full Text] [Related]
12. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation Through Targeting Interleukin-17.
Wang LX; Kang ZP; Yang ZC; Ma RX; Tan Y; Peng XB; Dai RZ; Li J; Yu Y; Xu M
Cell Physiol Biochem; 2018; 46(6):2232-2238. PubMed ID: 29734196
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
15. Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.
Wang HY; Yan LX; Shao Q; Fu S; Zhang ZC; Ye W; Zeng YX; Shao JY
Clin Chem; 2014 May; 60(5):773-82. PubMed ID: 24563490
[TBL] [Abstract][Full Text] [Related]
16. MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7.
Xu J; Ai Q; Cao H; Liu Q
Med Sci Monit; 2015 Sep; 21():2828-36. PubMed ID: 26390174
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of plasma miR-24 dysregulation in nasopharyngeal carcinoma].
Wang L; Yu B; Cen J; Peng X; Liu Y; Zeng F; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):743-7. PubMed ID: 26018275
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
20. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
